Nasopharyngeal carcinoma treated with bevacizumab combined with paclitaxel liposome plus cisplatin: a case report and literature review

Patients with stage IV nasopharyngeal carcinoma (NPC) have a poor prognosis, even with effective chemotherapy. Target agents combined with chemotherapy may improve NPC patients’ outcome. The case of a patient with NPC, who was treated by adding bevacizumab to chemotherapy after disease progression u...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Wan, Zou, Chang, Tian, Zhongkai, Tan, Wenyong, Shen, Weixi, Chen, Jinghua, Liu, Liping, Xu, Ruilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189977/
https://www.ncbi.nlm.nih.gov/pubmed/28053541
http://dx.doi.org/10.2147/OTT.S122238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189977/
https://www.ncbi.nlm.nih.gov/pubmed/28053541
http://dx.doi.org/10.2147/OTT.S122238

Ejemplares similares